George Arida
Chief Financial Officer (acting)
George Arida has 25 years’ experience as a venture capital fund manager, and previously worked in a range of technical, management, and executive positions in private and public companies. He currently serves as Chief Financial Officer for Clarametyx, and has extensive board and CFO/COO experience in early- and revenue-stage companies, including as board chair for ZyStor Therapeutics (acquired by BioMarin), Nerities (acquired by Kensey Nash, now DSM), Celleration (acquired by Alliqua Biomedical), Chromatin (acquired by S&W Seeds). George was previously CFO for BlueWillow Biologics and Capital Resource Advisors (acquired by RogersCasey), and has over a decade of prior experience in industry. He has a BS in Chemical Engineering from University of Illinois at Urbana-Champaign and an MBA from University of Chicago Booth School of Business.